Dr Mourad Rezk joined Biogen in January 2015. He is a medical doctor who trained as a diabetologist. He brings more than 20 years of experience in the pharmaceutical industry, holding a number of leadership roles in medical affairs, R&D and marketing.
Before joining Biogen, Dr Rezk was with Amgen for nearly eight years as an international medical lead for nephrology innovator biologics and the company’s EU biosimilars taskforce. While there, he established an internal biosimilars medical platform and led the development and execution of a significant number of multinational studies, key publications and poster presentations. He has also spoken at a number of key international biosimilars congresses.
Prior to that, Dr Rezk spent four years in Athens with Novo Nordisk Africa & Gulf as the region’s medical affairs director, establishing diabetes and hematology clinical and medical educational infrastructures that supported the launch of the company’s second‐generation insulin analogues and haemophilia treatments. He also previously spent nearly 11 years with J&J Middle East where he was marketing & sales lead for the biotech business unit, after which he moved to head the medical affairs team.